Help | RSS Feed



Oncolytics Biotech (TSE:ONC) Seasonal Chart

Oncolytics Biotech (TSE:ONC) Seasonality

ONC.TO Relative to the S&P 500
ONC.TO Relative to the S&P 500

ONC.TO Relative to the Sector
ONC.TO Relative to the Sector

Monthly Seasonal Oncolytics Biotech (TSE:ONC)

Seasonal Chart Analysis

Analysis of the Oncolytics Biotech (TSE:ONC) seasonal charts above shows that a Buy Date of December 16 and a Sell Date of March 13 has resulted in a geometric average return of 9.24% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 28.43% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Oncolytics Biotech Inc is a development stage biopharmaceutical company.
It is engaged in the discovery and development of pharmaceutical products for
the treatment of cancer that have not been successfully treated with conventional therapeutics.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...